‹ Back
KLOW Blend
The story
KLOW joins four research lines. BPC-157 came from Predrag Sikiric's Zagreb work on stomach protection from 1993. Thymosin beta-4 came from Allan Goldstein's thymus work and its wound biology at the US National Institutes of Health. GHK-Cu came from Loren Pickart's 1973 plasma discovery. KPV came from Anna Catania and James Lipton's work on alpha-MSH, with gut work at Emory in 2008. Practitioners added KPV to GLOW to calm inflammation, and the K went on the front of the name.
Sources
Read the original sources
- A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. (Sikirić · 1993 · Abstract; full methods not assumed · checked 2026-10-13)
- Thymosin beta4 accelerates wound healing. (Malinda · 1999 · Abstract; full methods not assumed · checked 2026-10-13)
- Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver (Abstract · checked 2026-10-13)
- Targeting melanocortin receptors as a novel strategy to control inflammation (Abstract · checked 2026-10-13)
- KPV: cell signals and mouse colitis (Dalmasso and colleagues · 2008 · Published abstract · checked 2026-10-08)